Correlation Between ScinoPharm Taiwan and Standard Chemical
Can any of the company-specific risk be diversified away by investing in both ScinoPharm Taiwan and Standard Chemical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ScinoPharm Taiwan and Standard Chemical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ScinoPharm Taiwan and Standard Chemical Pharmaceutical, you can compare the effects of market volatilities on ScinoPharm Taiwan and Standard Chemical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ScinoPharm Taiwan with a short position of Standard Chemical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ScinoPharm Taiwan and Standard Chemical.
Diversification Opportunities for ScinoPharm Taiwan and Standard Chemical
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ScinoPharm and Standard is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding ScinoPharm Taiwan and Standard Chemical Pharmaceutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Standard Chemical and ScinoPharm Taiwan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ScinoPharm Taiwan are associated (or correlated) with Standard Chemical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Standard Chemical has no effect on the direction of ScinoPharm Taiwan i.e., ScinoPharm Taiwan and Standard Chemical go up and down completely randomly.
Pair Corralation between ScinoPharm Taiwan and Standard Chemical
Assuming the 90 days trading horizon ScinoPharm Taiwan is expected to under-perform the Standard Chemical. In addition to that, ScinoPharm Taiwan is 1.36 times more volatile than Standard Chemical Pharmaceutical. It trades about -0.02 of its total potential returns per unit of risk. Standard Chemical Pharmaceutical is currently generating about -0.01 per unit of volatility. If you would invest 6,170 in Standard Chemical Pharmaceutical on December 30, 2024 and sell it today you would lose (40.00) from holding Standard Chemical Pharmaceutical or give up 0.65% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
ScinoPharm Taiwan vs. Standard Chemical Pharmaceutic
Performance |
Timeline |
ScinoPharm Taiwan |
Standard Chemical |
ScinoPharm Taiwan and Standard Chemical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ScinoPharm Taiwan and Standard Chemical
The main advantage of trading using opposite ScinoPharm Taiwan and Standard Chemical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ScinoPharm Taiwan position performs unexpectedly, Standard Chemical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Chemical will offset losses from the drop in Standard Chemical's long position.ScinoPharm Taiwan vs. United Radiant Technology | ScinoPharm Taiwan vs. Castles Technology Co | ScinoPharm Taiwan vs. Level Biotechnology | ScinoPharm Taiwan vs. Est Global Apparel |
Standard Chemical vs. Sinphar Pharmaceutical Co | Standard Chemical vs. Grape King Bio | Standard Chemical vs. Apex Biotechnology Corp | Standard Chemical vs. Maywufa Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets |